These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia. Sackmann Muriel F; Svarch E; Pavlovsky S; Bustelo P; Giuntoli J; Vergara B; Garay G; Eppinger-Helft M; Kvicala R; Dibar E Cancer Treat Rep; 1984 Apr; 68(4):581-6. PubMed ID: 6370428 [TBL] [Abstract][Full Text] [Related]
3. Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L. Dahl GV; Rivera GK; Look AT; Hustu HO; Kalwinsky DK; Abromowitch M; Mirro J; Ochs J; Murphy SB; Dodge RK J Clin Oncol; 1987 Jul; 5(7):1015-21. PubMed ID: 3474355 [TBL] [Abstract][Full Text] [Related]
4. Intermediate-risk childhood acute lymphoblastic leukemias: amsacrine + cytosine arabinoside versus intermediate-dose methotrexate for consolidation, and 6-mercaptopurine + methotrexate + vincristine versus monthly pulses for maintenance. Schaison G; Leverger G; Bancillon A; Marty M; Olive D; Cornu G; Griscelli C; Lemerle S; Harousseau JL; Bonnet M Haematol Blood Transfus; 1987; 30():461-5. PubMed ID: 3305213 [No Abstract] [Full Text] [Related]
5. Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study. Pullen J; Boyett J; Shuster J; Crist W; Land V; Frankel L; Iyer R; Backstrom L; van Eys J; Harris M J Clin Oncol; 1993 May; 11(5):839-49. PubMed ID: 8487048 [TBL] [Abstract][Full Text] [Related]
6. A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood. A Pediatric Oncology Group Study. van Eys J; Berry D; Crist W; Doering E; Fernbach D; Pullen J; Shuster J; Wharam M Cancer; 1989 Jan; 63(1):23-9. PubMed ID: 2910421 [TBL] [Abstract][Full Text] [Related]
7. Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group study. Sullivan MP; Chen T; Dyment PG; Hvizdala E; Steuber CP Blood; 1982 Oct; 60(4):948-58. PubMed ID: 6956376 [TBL] [Abstract][Full Text] [Related]
8. [The Munich study on the treatment of acute lymphoblastic leukemia in childhood (ALL 77-02)]. Graubner UB; Haas RJ; Janka G; Gaedicke G; Kohne E; Rieber EP Klin Padiatr; 1985; 197(3):207-14. PubMed ID: 3892149 [TBL] [Abstract][Full Text] [Related]
9. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica. Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699 [TBL] [Abstract][Full Text] [Related]
10. Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia. Winick NJ; Bowman WP; Kamen BA; Roach ES; Rollins N; Jacaruso D; Buchanan GR J Natl Cancer Inst; 1992 Feb; 84(4):252-6. PubMed ID: 1734087 [TBL] [Abstract][Full Text] [Related]
11. A pilot study of intermediate-dose methotrexate and cytosine arabinoside, "spread-out" or "up-front," in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia. A Pediatric Oncology Group study. Krance RA; Newman EM; Ravindranath Y; Harris MB; Brecher M; Wimmer R; Shuster JJ; Land VJ; Pullen J; Crist W Cancer; 1991 Feb; 67(3):550-6. PubMed ID: 1985748 [TBL] [Abstract][Full Text] [Related]
12. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial. Millot F; Suciu S; Philippe N; Benoit Y; Mazingue F; Uyttebroeck A; Lutz P; Mechinaud F; Robert A; Boutard P; Marguerite G; Ferster A; Plouvier E; Rialland X; Behard C; Plantaz D; Dresse MF; Philippet P; Norton L; Thyss A; Dastugue N; Waterkeyn C; Vilmer E; Otten J; J Clin Oncol; 2001 Apr; 19(7):1935-42. PubMed ID: 11283125 [TBL] [Abstract][Full Text] [Related]
13. Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group. Crist W; Shuster J; Look T; Borowitz M; Behm F; Bowman P; Frankel L; Pullen J; Krance R; Steuber P Leukemia; 1992; 6 Suppl 2():162-6. PubMed ID: 1578922 [TBL] [Abstract][Full Text] [Related]
14. [Acute lymphoblastic leukemia in children. Long survivals obtained with protocols C2-72 and D-74 (1972-1977)]. Ortega JJ; Javier G; Montagut JM; Torán N An Esp Pediatr; 1986 Feb; 24(2):87-97. PubMed ID: 3516041 [TBL] [Abstract][Full Text] [Related]
15. Intensive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: A Pediatric Oncology Group Pilot Study. Lauer SJ; Camitta BM; Leventhal BG; Mahoney D; Shuster JJ; Kiefer G; Pullen J; Steuber CP; Carroll AJ; Kamen B J Pediatr Hematol Oncol; 1998; 20(3):229-33. PubMed ID: 9628434 [TBL] [Abstract][Full Text] [Related]
16. Teniposide plus cytarabine as intensification therapy and in continuation therapy for advanced nonlymphoblastic lymphomas of childhood. Maluf PT; Odone Filho V; Cristofani LM; Britto JL; Almeida MT; Pontes E; Maksoud JG; Manissadjian A J Clin Oncol; 1994 Sep; 12(9):1963-8. PubMed ID: 8083717 [TBL] [Abstract][Full Text] [Related]
17. [Results of the CCLSG high risk ALL 874 protocol in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group]. Kawai S; Fujimoto T; Zha Z; Asami K; Oka T; Kaneko Y; Takaue Y; Ninomiya T; Nishikawa K; Tsuchiya T Rinsho Ketsueki; 1993 Feb; 34(2):128-36. PubMed ID: 8492409 [TBL] [Abstract][Full Text] [Related]
18. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia. Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E; Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744 [TBL] [Abstract][Full Text] [Related]
19. Treatment of occult or late overt testicular relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. Wofford MM; Smith SD; Shuster JJ; Johnson W; Buchanan GR; Wharam MD; Ritchey AK; Rosen D; Haggard ME; Golembe BL J Clin Oncol; 1992 Apr; 10(4):624-30. PubMed ID: 1548525 [TBL] [Abstract][Full Text] [Related]
20. Comparison of intermittent or continuous methotrexate plus 6-mercaptopurine in regimens for standard-risk acute lymphoblastic leukemia in childhood (JCCLSG-S811). The Japanese Children's Cancer and Leukemia Study Group. Koizumi S; Fujimoto T; Takeda T; Yatabe M; Utsumi J; Mimaya J; Ninomiya T; Yanai M Cancer; 1988 Apr; 61(7):1292-300. PubMed ID: 3278798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]